Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 28, Issue 5, Pages 1031-1041
Publisher
Springer Science and Business Media LLC
Online
2022-03-31
DOI
10.1038/s41591-022-01780-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study
- (2021) Billy J Quilty et al. Lancet Public Health
- Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis
- (2021) Gopiram Syangtan et al. Frontiers in Public Health
- Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients
- (2021) Dieter Munker et al. EUROPEAN RESPIRATORY JOURNAL
- Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study
- (2021) Michael Marks et al. LANCET INFECTIOUS DISEASES
- Duration of Culturable SARS-CoV-2 in Hospitalized Patients with Covid-19
- (2021) Min-Chul Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Innate-like Gene Expression of Lung-resident Memory CD8+ T-cells During Experimental Human Influenza: A Clinical Study
- (2021) Suzanna Paterson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19
- (2021) Andreas Barratt-Due et al. ANNALS OF INTERNAL MEDICINE
- Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
- (2021) Thomas M Drake et al. LANCET
- SARS-CoV-2 Human Challenge Studies — Establishing the Model during an Evolving Pandemic
- (2021) Garth Rapeport et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters
- (2021) Rana Abdelnabi et al. EBioMedicine
- Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis
- (2021) Marion Renaud et al. JAMA Network Open
- Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
- (2021) Anika Singanayagam et al. LANCET INFECTIOUS DISEASES
- Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
- (2021) Matan Levine-Tiefenbrun et al. NATURE MEDICINE
- Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
- (2021) Robert L. Gottlieb et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness
- (2021) Ruian Ke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
- (2021) William A. Fischer et al. Science Translational Medicine
- Recalibrating SARS-CoV-2 Antigen Rapid Lateral Flow Test Relative Sensitivity from Validation Studies to Absolute Sensitivity for Indicating Individuals Shedding Transmissible Virus
- (2021) Irene Petersen et al. Clinical Epidemiology
- A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period
- (2020) Ping Yu et al. JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
- (2020) Lirong Zou et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
- (2020) Stephen A. Lauer et al. ANNALS OF INTERNAL MEDICINE
- SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
- (2020) Yixuan J. Hou et al. CELL
- Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
- (2020) Sin Fun Sia et al. NATURE
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- Temporal dynamics in viral shedding and transmissibility of COVID-19
- (2020) Xi He et al. NATURE MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation
- (2020) D. Gbesemete et al. BMC Medicine
- SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19
- (2020) Stéphanie Baggio et al. CLINICAL INFECTIOUS DISEASES
- Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis
- (2020) Jingjing He et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models
- (2020) Meagan E. Deming et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
- (2020) Masaki Imai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment
- (2020) Jonathan S. Nguyen-Van-Tam et al. PLoS Pathogens
- SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues
- (2020) Marc Baay et al. BIOLOGICALS
- Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers
- (2020) Myron M Levine et al. CLINICAL INFECTIOUS DISEASES
- SARS-CoV-2 detection, viral load and infectivity over the course of an infection
- (2020) Kieran A. Walsh et al. JOURNAL OF INFECTION
- Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection
- (2020) Rafal Butowt et al. NEUROSCIENTIST
- Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection
- (2020) Maximillian S. Habibi et al. SCIENCE
- RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients
- (2020) Kirsten Alexandra Eberhardt et al. Viruses-Basel
- Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study
- (2020) Ash K Clift et al. BMJ-British Medical Journal
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection
- (2015) Agnieszka Jozwik et al. Nature Communications
- Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals
- (2013) Bindiya Bagga et al. ANTIVIRAL THERAPY
- Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus
- (2010) John P. DeVincenzo et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now